(Total Views: 410)
Posted On: 05/18/2025 9:26:52 PM
Post# of 155734
“ I guess what i'm saying is co-morbities...lifestyle...genetics have to play some part in the equation.”
Check out figure 4. From ESMO poster. Specially the pre-Leronlimab Pd-L1 levels as compared to the post-Leronlimab pd-L1 levels.
You will see a history of individuals. Some showing very low levels of PD-L1 pre-Leronlimab may have been too far gone to respond to this particular intervention, esp the 350mg ‘black box’ individuals.
https://d1io3yog0oux5.cloudfront.net/_57f1875...28h%29.pdf
Check out figure 4. From ESMO poster. Specially the pre-Leronlimab Pd-L1 levels as compared to the post-Leronlimab pd-L1 levels.
You will see a history of individuals. Some showing very low levels of PD-L1 pre-Leronlimab may have been too far gone to respond to this particular intervention, esp the 350mg ‘black box’ individuals.
https://d1io3yog0oux5.cloudfront.net/_57f1875...28h%29.pdf
(2)
(0)
